DERMABOND® Mini Topical Skin Adhesive

A protective barrier that adds strength and inhibits bacteria

• Provides a microbial barrier with 99% protection in vitro for 72 hours against organisms commonly responsible for SSIs²

• Demonstrates inhibition of gram-positive bacteria (MRSA and MRSE) and gram-negative bacteria (E coli) in vitro

Unique formulation with additional value

• Addresses cost and convenience concerns by eliminating the need for return visits to remove suture

• Offers fast closure of small incisions and lacerations
• Provides patient comfort by providing flexible closure without the pain or anxiety caused by needles

Click here to learn more about Dermabond Mini

DERMABOND® ADVANCED™ Topical Skin Adhesive

Designed for easy use and application

Patient Comfort & Satisfaction

• In a prospective randomised study of minimally invasive vein harvest closure in 106 patients surgeries, patient satisfaction, colour and visibility of scar was significantly better with Dermabond® Adhesive at 6 weeks 

• In a retrospective study of bilateral mammoplasties in 670 patients, patient comfort and satisfaction were also superior with DERMABOND® Adhesive

• Patients can shower immediately as directed by their physician

Reduced Incidence of SSIs

• After CABG surgery, the incidence of SSIs was reduced by 57% for wounds closed with DERMABOND® Adhesive in addition to sutures, compared to wounds closed with sutures alone

Decreased Length of Stay

• The use of DERMABOND® Adhesive in CABG surgery was associated with allowing patients to return home 4 days earlier (9 days stay, instead of 13) 

DERMABOND® PRINEO® Skin Closure System

A combination of 2-octyl cyanoacrylate (2-OCA) and a self-adhering mesh

Protection

• Provides microbial-barrier protection 99% effective in vitro for 72 hours against organisms commonly responsible for surgical site infection (SSI)²
• Demonstrates in vitro inhibition of bacteria (Methicillin-resistant Staphylococcus aureus, Methicillin-resistant Staphylococcus epidermidis, Escherichia coli)

Strength

• Significantly greater skin holding strength than skin staples or subcuticular suture
• Redistributes tension away from the wound to the surrounding healthy surface area

Patient Satisfaction

• Patient may be able to shower immediately after the procedure, if directed by the healthcare professional
• At the time of removal, DERMABOND® PRINEO® System is associated with less pain than other wound closure devices
• No post-surgical dressings may mean easier selfcare and greater self-confidence for patients

DERMABOND® PRINEO® family continues to grow, offering a closure solution for more surgical wounds - (22cm, 42cm and 60cm)

DERMABOND PRINEO System combinesthe proven strength, ­flexibility, and antimicrobial protection of DERMABOND ADVANCED® Topical Skin Adhesive with the added support and security of a self-adhering mesh to further facilitate both wound-edge approximation and an optimal healing environment⁴.

Shown to provide statistically significant greater skin-holding strength than skin staples or subcuticular suture.

Request More Information

Please fill in the form below to request more information and/or free samples of Dermabond products.

References: 

1. Data on file. Ethicon Inc. Report: Protocol to determine the strength benefits when adding Dermabond Advanced Topical Skin Adhesive to wound using suture as the primary closure. 2011 
2. Bhende S, et al in Vitro Assessment of Microbial Barrier properties of Dermabond, Topical skin Adhesive, Surgical Infections, 2002,3,251-257 
3. Bhende S, Rothenburger S, Spangler DJ, Ditto M, In Vitro assessment of microbial barrier properties of Dermabond Topical skin adhesive. Surg Infect 2002;3(3) 251-257 
4. Dermabond Prineo Skin Closure System (22cm ) instructions for use Ethicon Inc.